The developer of a nasal spray is claiming that its anti-viral nasal spray may significantly reduce the infectivity of respiratory and cold viruses, including the CCP (Chinese Communist Party) virus.
The data published on July 27, by the Australian-based company Starpharma claims that its research at the Scripps Research Institute in the United States into astodrimer sodium (SPL7013) revealed the substance was able to inactivate over 99 percent of the CCP virus, including the Delta and Kappa variants.
